Skip to nav Skip to content

News Releases and Statements

Facebook Twitter LinkedIn Email

Public Comment Period for IDSA/AAN/ACR Draft Lyme Disease Guidelines Extended through Sept. 9

The Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR) have extended the public comment period for the draft of their joint guidelines for the prevention, diagnosis, and treatment of Lyme disease for an additional 30 days.

Increased CMS Reimbursements for New Antibiotics Represents Progress in Attention to AMR

The Centers for Medicare and Medicaid Services Inpatient Prospective Payment System rule for the coming fiscal year will raise reimbursements for novel antibiotics, a meaningful step in confronting the threat of infections resistant to older medicines.

HIV Status Has No Place in Border Patrol Policy

IDSA, HIVMA, SHEA and PIDS call for humane, evidenced-based border policies that reflect the science and adhere to ID prevention and treatment protocols.

Declaration of PHEIC in DRC Should Spur Support, Not Fear

The World Health Organization’s declaration today that the year-long Ebola crisis is a Public Health Emergency of International Concern is hoped to raise much-needed awareness and resources for preparedness and control efforts across the region.

AMR Crisis Demands Immediate Action, IDSA Treasurer Tells Legislators

IDSA Board Member Dr. Helen Boucher, FIDSA, described AMR challenges, solutions to members of the House Oversight and Reform National Security subcommittee in June 26 testimony, urging lawmakers to incentivize development of new antibiotics and protect existing ones.

Public Comment Period for IDSA/AAN/ACR Draft Lyme Disease Guidelines Open

The Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR) have opened a public comment period for the draft of their joint guidelines for the prevention, diagnosis, and treatment of Lyme disease.

Reauthorization of PAHPA Builds Foundation for Public Health Readiness

The reauthorization of the Pandemic and All Hazards Preparedness Act signed by the president Monday includes measures that are critical to ensure that our nation has the resources and expertise needed to confront, control and combat emerging public health threats.

House FY 2020 Appropriations Respond to Most Infectious Disease and HIV Realities

With increased funds for important federal programs and interventions responding to infectious diseases and HIV, the health, foreign operations, and defense spending bill for fiscal year 2020 passed by the House of Representatives Wednesday reflects an understanding of a broad scope of public health threats at home and around the world, and of the resources needed to address them.

Lower Health Care Costs Act Highlights the Value of Vaccines

The Senate Health, Education, Labor and Pensions Committee hearing today on the Lower Health Care Costs Act provides a valuable opportunity for lawmakers to address challenges compromising access to and uptake of vaccines that are among our most important public health tools.

Infectious Diseases Society of America Announces Move to Ballston Quarter

The Infectious Diseases Society of America announced today that it will be relocating its headquarters to 4040 Wilson Boulevard in the Ballston Quarter area of Arlington, Va., a hub of advanced research learning, technology and science in the Washington, D.C. metro area.

Cross-Border Spread of DCR Ebola Outbreak Calls for Immediate, Ongoing Responses

Uganda health officials’ confirmation today of Ebola virus among family members who travelled from the Democratic Republic of Congo brings with it the realization of a concern that has been noted since the August 2018 recognition of the current outbreak.

IDSA Foundation Offers $500,000 in Research Grants to Study Possible Connection

The Infectious Diseases Society of America (IDSA) Foundation, with generous support from Alzheimer’s Germ Quest, Inc. and The Benter Foundation is offering five, one-time $100,000 grants to researchers seeking to identify a potential infectious link to the disease.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.